Memorialsloanxettei-ing CancerCenber August 7, 2018 Marc Rosenblum, MD Chief. Autopsy Service Director, Founder's Chair Department oi Pathology MS KCC Dear Dr. Rosco lum, This is to inform )ou that I am a consultant and equity holder with an entity called PAIGEAI, a commercial company devoted to research in the areas of digital and mmputalional pathology, Research conducted by PAIGEAI may thematically overlap with research in digital and computational pathology being conducted at MSK by members ottho Department uf Pathology, mcludlng trainees, creating a potential for financial conflict of interest. Other members of the, pathology Department will also be engaged with PAIGEAI in various capacities. The purpose of this notification is to inform you ofthese potential ofintei-est and limits management of the conflicts. it is incumbent on you (0 inform iaeulty and trainees on your seniee who may be engaged in, or considering, research on these tnpics about this conflict the existence or the institutional management plan, and options to address any concern. they may have, Ifyoii have general questions ahout management plans, you may contact England, Patholngy Administrator or Kristen Ahcarn. Associate General Counsel, Director. Compliance and Privacy officer. If at any time you ieel that your scholarly progress or employment status is compromised by this relationship or you feel undo pressure to participate in research related to these topics, you may contact Melissa Pessin, Chair of the Department of Laboratory Medicine. Si ticcrely, flay-id s. MD. (hall. or parholoet out new to rat at has -- Maw note>> nea Cantu